Supplementation of Dihomo-γ-Linolenic Acid for Pollen-Induced Allergic Symptoms in Healthy Subjects: A Randomized, Double-Blinded, Placebo-Controlled Trial

Overview

Journal Nutrients

Date 2023 Aug 12

PMID 37571402

Authors

Kaori Yokoi

Kenichi Yanagimoto

Kohsuke Hayamizu

Affiliations

Soon will be listed here.

Abstract

Dihomo-γ-linolenic acid (DGLA) is an -6 polyunsaturated fatty acid that has been shown to have anti-inflammatory and anti-allergic effects in mice and cell study. To date, however, no human intervention study has examined the effects of DGLA. Therefore, we investigated the effects of DGLA on pollen-induced allergic symptoms in healthy adults. We performed a randomized, double-blind, placebo-controlled, parallel-group study comprising healthy Japanese men and women. Each subject received four 250 mg capsules providing 314 mg DGLA/day (DGLA group, n = 18) or olive oil (placebo group, n = 15) for 15 weeks. The primary outcomes, classification of the severity of allergic rhinitis symptoms (CSARS), and the Japanese Rhino-conjunctivitis Quality of Life Questionnaire (JRQLQ) served as symptom scores during the pollen season. In the DGLA group, the cedar pollen associated symptoms of sneezing and a blocked nose in the CSARS were significantly lower than those in the placebo group ( < 0.05, < 0.01, respectively). Significant trends were observed the symptoms of runny nose in the CSARS and total symptom score (TSS) in the JRQLQ for cedar pollen ( < 0.1). To our knowledge, this is the first study to report the effects of DGLA in humans, and the results suggest that DGLA is effective in reducing allergic symptoms caused by pollen.

References

Zurier R, Rossetti R, Seiler C, Laposata M . Human peripheral blood T lymphocyte proliferation after activation of the T cell receptor: effects of unsaturated fatty acids. Prostaglandins Leukot Essent Fatty Acids. 1999; 60(5-6):371-5. DOI: 10.1016/s0952-3278(99)80015-5. View

Flower R, Kingston W . Proceedings: Prostaglandin D1 inhibits the increase in vascular permeability in rat skin produced by prostaglandin E1, E2 and D2. Br J Pharmacol. 1975; 55(2):239P-240P. PMC: 1666856. DOI: 10.1111/j.1476-5381.1975.tb07634.x. View

Williams C, Whitley B, Hoyo C, Grant D, Iraggi J, Newman K . A high ratio of dietary n-6/n-3 polyunsaturated fatty acids is associated with increased risk of prostate cancer. Nutr Res. 2011; 31(1):1-8. DOI: 10.1016/j.nutres.2011.01.002. View

Dooper M, van Riel B, Graus Y, MRabet L . Dihomo-gamma-linolenic acid inhibits tumour necrosis factor-alpha production by human leucocytes independently of cyclooxygenase activity. Immunology. 2003; 110(3):348-57. PMC: 1783054. DOI: 10.1046/j.1365-2567.2003.01749.x. View

Brozek J, Bousquet J, Agache I, Agarwal A, Bachert C, Bosnic-Anticevich S . Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines-2016 revision. J Allergy Clin Immunol. 2017; 140(4):950-958. DOI: 10.1016/j.jaci.2017.03.050. View

Ouchi S, Miyazaki T, Shimada K, Sugita Y, Shimizu M, Murata A . Decreased circulating dihomo-gamma-linolenic acid levels are associated with total mortality in patients with acute cardiovascular disease and acute decompensated heart failure. Lipids Health Dis. 2017; 16(1):150. PMC: 5556673. DOI: 10.1186/s12944-017-0542-2. View

Tanaka T, Kakutani S, Horikawa C, Kawashima H, Kiso Y . Oral supplementation with dihomo-γ-linolenic acid (DGLA)-enriched oil increases serum DGLA content in healthy adults. Lipids. 2012; 47(6):643-6. DOI: 10.1007/s11745-012-3664-3. View

Okuda M, Okubo K, Gotoh M, Okamoto Y, Imano A, Baba K . [Standard questionnaire for QOL of Japanese patients with allergic rhinitis]. Arerugi. 2003; 52 Suppl 1:21-56. View

Kanda N, Hoashi T, Saeki H . Nutrition and Atopic Dermatitis. J Nippon Med Sch. 2021; 88(3):171-177. DOI: 10.1272/jnms.JNMS.2021_88-317. View

10.

Levin G, Duffin K, Obukowicz M, Hummert S, Fujiwara H, Needleman P . Differential metabolism of dihomo-gamma-linolenic acid and arachidonic acid by cyclo-oxygenase-1 and cyclo-oxygenase-2: implications for cellular synthesis of prostaglandin E1 and prostaglandin E2. Biochem J. 2002; 365(Pt 2):489-96. PMC: 1222686. DOI: 10.1042/BJ20011798. View

11.

Li J, Yang P, Li A, Wang Y, Ke Y, Li X . Cardioprotective effect of liposomal prostaglandin E1 on a porcine model of myocardial infarction reperfusion no-reflow. J Zhejiang Univ Sci B. 2011; 12(8):638-43. PMC: 3150717. DOI: 10.1631/jzus.B1101007. View

12.

Ruan K, Cervantes V, So S . Engineering of a novel hybrid enzyme: an anti-inflammatory drug target with triple catalytic activities directly converting arachidonic acid into the inflammatory prostaglandin E2. Protein Eng Des Sel. 2009; 22(12):733-40. PMC: 2777022. DOI: 10.1093/protein/gzp058. View

13.

Santoli D, Zurier R . Prostaglandin E precursor fatty acids inhibit human IL-2 production by a prostaglandin E-independent mechanism. J Immunol. 1989; 143(4):1303-9. View

14.

Larche M, Akdis C, Valenta R . Immunological mechanisms of allergen-specific immunotherapy. Nat Rev Immunol. 2006; 6(10):761-71. DOI: 10.1038/nri1934. View

15.

van Gool C, Thijs C, Henquet C, Van Houwelingen A, Dagnelie P, Schrander J . Gamma-linolenic acid supplementation for prophylaxis of atopic dermatitis--a randomized controlled trial in infants at high familial risk. Am J Clin Nutr. 2003; 77(4):943-51. DOI: 10.1093/ajcn/77.4.943. View

16.

Kawashima H, Tateishi N, Shiraishi A, Teraoka N, Tanaka T, Tanaka A . Oral administration of dihomo-gamma-linolenic acid prevents development of atopic dermatitis in NC/Nga mice. Lipids. 2007; 43(1):37-43. DOI: 10.1007/s11745-007-3129-2. View

17.

Yamaoka K, Dugas B, Paul-Eugene N, Mencia-Huerta J, Braquet P, Kolb J . Leukotriene B4 enhances IL-4-induced IgE production from normal human lymphocytes. Cell Immunol. 1994; 156(1):124-34. DOI: 10.1006/cimm.1994.1158. View

18.

Sakurai E, Gunji E, Iizuka Y, Hikichi N, Maeyama K, Watanabe T . In vivo microdialysis measurement of histamine in rat blood effects of compound 48/80 and histamine receptor antagonists. J Pharmacol Toxicol Methods. 1993; 29(2):105-9. DOI: 10.1016/1056-8719(93)90058-m. View

19.

Okubo K, Kurono Y, Fujieda S, Ogino S, Uchio E, Odajima H . Japanese guideline for allergic rhinitis. Allergol Int. 2011; 60(2):171-89. DOI: 10.2332/allergolint.11-rai-0334. View

20.

Takano H, Osakabe N, Sanbongi C, Yanagisawa R, Inoue K, Yasuda A . Extract of Perilla frutescens enriched for rosmarinic acid, a polyphenolic phytochemical, inhibits seasonal allergic rhinoconjunctivitis in humans. Exp Biol Med (Maywood). 2004; 229(3):247-54. DOI: 10.1177/153537020422900305. View